Freshpet (FRPT)
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-09-04
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-09-04
Warn: Management is running behind on a stated commitment.
Freshpet grows revenue about 13% yearly, reaching $297.6M in 2026-Q1. Profit margins improved to 40.5% in 2026-Q1. Net income rose from a loss to $48.5M in 2026-Q1. Management guides disciplined capital spending near $150M with positive cash flow.
Leadership changes may disrupt strategy and execution. Recent selloff shows investor concerns. Revenue growth and margin gains could slow amid sector headwinds.
The price is about 6% above our fair value near $51, reflecting roughly 11% revenue growth. Our fair value is 32% below the Street median, indicating some caution versus optimistic analyst targets.
Breaks if: Capital expenditures exceed $175 million in 2026
Generate positive free cash flow while managing capital expenditures around $150 million annually.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth opportunity in the Consumer Staples sector. The current thesis state is intact, driven by recent revenue growth and improved profitability, though risks remain elevated.
The market appears to price in a premium compared to peers, indicating expectations for continued growth. However, there is an expectations gap suggesting that the current valuation may not fully reflect the underlying risks and uncertainties.
Management is focused on increasing revenue growth and enhancing net income, showing positive trends in these areas. However, gross profit margins are improving at a mixed pace, and there is a low probability of missing guidance, despite recent industry challenges.
The thesis hinges on maintaining revenue growth and margin improvements while navigating sector headwinds. Key factors include the performance of sector bellwethers and any shifts in inflation rates that could impact the Consumer Staples sector.
The most important moves since the prior daily snapshot.
Confidence changed from 'high' to 'medium'.
Yes, our read has strengthened. The latest earnings beat supports an increase in revenue growth. Strong sales directly reinforce this revenue growth objective. There are no new threats impacting the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 4 of last 4 quarters. Management maintained guidance for positive free cash flow with capital expenditures around $150 million for 2026, down from $175 million in 2025. The trajectory shows disciplined capex management supporting positive cash flow.
“Positive Free Cash Flow with capital expenditures of ~$150 million, unchanged from previous guidance.”
“Positive free cash flow with capital expenditures of ~$150 million.”
“Capital expenditures of ~$140 million, compared to ~$175 million previously.”
“Capital expenditures of ~$175 million, compared to ~$225 million previously.”
Breaks if: Gross margin falls below 39%
Enhance adjusted gross margin through lower input costs, operational leverage, and new technology lines.
Stated as a priority in 4 of last 4 quarters. Adjusted Gross Margin improved from 46.9% in 2025-Q2 to 48.6% in 2026-Q2. Management updated long-term guidance to at least 49% for 2027 from prior 48%. The trajectory shows steady margin improvement and raised targets.
“Adjusted Gross Margin of 48.6%, compared to 46.9% prior year.”
“Adjusted Gross Margin of 46.9%, compared to 45.7% prior year.”
“Adjusted Gross Margin of 48.4%, compared to 48.1% prior year.”
“Adjusted Gross Margin of 46.7% for full year 2025, compared to 46.5% prior year.”
Breaks if: Leadership changes cause strategic disruption or execution failure
Build leadership capabilities by appointing experienced executives in finance and supply chain roles.
Newly stated in 2026-Q1 period. Management announced strategic leadership hires in finance and supply chain to support growth and operational goals. No quantitative financial impact yet reported; this is an early-stage priority.
Breaks if: Net income falls below $30 million in 2026-Q1
Increase net income through higher sales, operational efficiencies, and gains on equity investments.
Stated as a priority in 4 of last 4 quarters. Net income increased from $16.4 million in 2025-Q2 to $19.5 million in 2026-Q2. Full year 2025 net income was $139.1 million, up from $46.9 million prior year. The trajectory shows consistent improvement in profitability.
“Net income of $19.5 million, compared to $16.4 million prior year.”
“Net income of $48.5 million, compared to net loss of $12.7 million prior year.”
“Net income of $33.8 million, compared to $18.1 million prior year.”
“Full year 2025 net income of $139.1 million, compared to $46.9 million prior year.”
Breaks if: Net sales fall below $285 million in 2026-Q1
Drive net sales growth through volume gains and market share expansion in the fresh pet food segment.
Stated as a priority in 4 of last 4 quarters. Revenue grew from $264.7 million in 2025-Q2 to $305.6 million in 2026-Q2, a 15.5% increase. Management raised 2026 net sales growth guidance to 10%-12% from prior 8%-11%. The trajectory is delivering with accelerating growth and raised guidance.
“Net sales of $305.6 million, an increase of 15.5%.”
“Net sales of $297.6 million, an increase of 13.1%.”
“Net sales of $285.2 million, an increase of 8.6%.”
“Full year 2025 net sales growth of 13%.”
Over the next 1 to 3 years, FRPT's performance will depend on its ability to sustain growth and manage risks effectively. Not investment advice.